ID   UD11_RAT                Reviewed;         535 AA.
AC   Q64550; Q64635;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   02-OCT-2024, entry version 156.
DE   RecName: Full=UDP-glucuronosyltransferase 1A1 {ECO:0000305};
DE            Short=UGT1A1;
DE            EC=2.4.1.17 {ECO:0000250|UniProtKB:P22309};
DE   AltName: Full=B1;
DE   AltName: Full=UDP-glucuronosyltransferase 1-1;
DE            Short=UDPGT 1-1;
DE            Short=UGT1*1;
DE            Short=UGT1-01;
DE            Short=UGT1.1;
DE   Flags: Precursor;
GN   Name=Ugt1a1 {ECO:0000312|RGD:3935}; Synonyms=Ugt1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Wistar;
RX   PubMed=7603447;
RA   Coffman B.L., Green M.D., King C.O., Tephly T.R.;
RT   "Cloning and stable expression of a cDNA encoding a rat liver UDP-
RT   glucuronosyltransferase (UDP-glucuronosyltransferase 1.1) that catalyzes
RT   the glucuronidation of opioids and bilirubin.";
RL   Mol. Pharmacol. 47:1101-1105(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-290.
RC   STRAIN=Wistar;
RX   PubMed=7608130; DOI=10.1093/jb/117.2.392;
RA   Emi Y., Ikushiro S., Iyanagi T.;
RT   "Drug-responsive and tissue-specific alternative expression of multiple
RT   first exons in rat UDP-glucuronosyltransferase family 1 (UGT1) gene
RT   complex.";
RL   J. Biochem. 117:392-399(1995).
RN   [3]
RP   PROTEIN SEQUENCE OF 30-41.
RX   PubMed=7986077; DOI=10.1006/abbi.1994.1510;
RA   Ishii Y., Tsuruda K., Tanaka M., Oguri K.;
RT   "Purification of a phenobarbital-inducible morphine UDP-
RT   glucuronyltransferase isoform, absent from Gunn rat liver.";
RL   Arch. Biochem. Biophys. 315:345-351(1994).
RN   [4]
RP   FUNCTION, AND INDUCTION BY 3-METHYLCHOLANTHRENE.
RX   PubMed=8554318; DOI=10.1006/abbi.1995.0039;
RA   Ikushiro S., Emi Y., Iyanagi T.;
RT   "Identification and analysis of drug-responsive expression of UDP-
RT   glucuronosyltransferase family 1 (UGT1) isozyme in rat hepatic microsomes
RT   using anti-peptide antibodies.";
RL   Arch. Biochem. Biophys. 324:267-272(1995).
CC   -!- FUNCTION: UDP-glucuronosyltransferase (UGT) that catalyzes phase II
CC       biotransformation reactions in which lipophilic substrates are
CC       conjugated with glucuronic acid to increase the metabolite's water
CC       solubility, thereby facilitating excretion into either the urine or
CC       bile (PubMed:8554318). Essential for the elimination and detoxification
CC       of drugs, xenobiotics and endogenous compounds (PubMed:8554318).
CC       Catalyzes the glucuronidation of endogenous estrogen hormones such as
CC       estradiol, estrone and estriol (By similarity). Involved in the
CC       glucuronidation of bilirubin, a degradation product occurring in the
CC       normal catabolic pathway that breaks down heme in vertebrates (By
CC       similarity). Also catalyzes the glucuronidation the isoflavones
CC       genistein, daidzein, glycitein, formononetin, biochanin A and prunetin,
CC       which are phytoestrogens with anticancer and cardiovascular properties
CC       (By similarity). Involved in the glucuronidation of the AGTR1
CC       angiotensin receptor antagonist losartan, a drug which can inhibit the
CC       effect of angiotensin II (By similarity). Involved in the
CC       biotransformation of 7-ethyl-10-hydroxycamptothecin (SN-38), the
CC       pharmacologically active metabolite of the anticancer drug irinotecan
CC       (By similarity). {ECO:0000250|UniProtKB:P22309,
CC       ECO:0000269|PubMed:8554318}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glucuronate acceptor + UDP-alpha-D-glucuronate = acceptor
CC         beta-D-glucuronoside + H(+) + UDP; Xref=Rhea:RHEA:21032,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:58052, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:132367, ChEBI:CHEBI:132368; EC=2.4.1.17;
CC         Evidence={ECO:0000250|UniProtKB:P22309};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:21033;
CC         Evidence={ECO:0000250|UniProtKB:P22309};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=17beta-estradiol + UDP-alpha-D-glucuronate = 17beta-estradiol
CC         3-O-(beta-D-glucuronate) + H(+) + UDP; Xref=Rhea:RHEA:52460,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16469, ChEBI:CHEBI:58052,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:136641;
CC         Evidence={ECO:0000250|UniProtKB:P22309};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52461;
CC         Evidence={ECO:0000250|UniProtKB:P22309};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-hydroxyestrone + UDP-alpha-D-glucuronate = 2-hydroxyestrone
CC         3-O-(beta-D-glucuronate) + H(+) + UDP; Xref=Rhea:RHEA:53048,
CC         ChEBI:CHEBI:1156, ChEBI:CHEBI:15378, ChEBI:CHEBI:58052,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:136967;
CC         Evidence={ECO:0000250|UniProtKB:P22309};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53049;
CC         Evidence={ECO:0000250|UniProtKB:P22309};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-hydroxy-17beta-estradiol + UDP-alpha-D-glucuronate = 2-
CC         hydroxy-17beta-estradiol 3-O-(beta-D-glucuronate) + H(+) + UDP;
CC         Xref=Rhea:RHEA:53004, ChEBI:CHEBI:15378, ChEBI:CHEBI:28744,
CC         ChEBI:CHEBI:58052, ChEBI:CHEBI:58223, ChEBI:CHEBI:136931;
CC         Evidence={ECO:0000250|UniProtKB:P22309};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53005;
CC         Evidence={ECO:0000250|UniProtKB:P22309};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-methoxy-17beta-estradiol + UDP-alpha-D-glucuronate = 2-
CC         methoxy-17beta-estradiol 3-O-(beta-D-glucuronate) + H(+) + UDP;
CC         Xref=Rhea:RHEA:53072, ChEBI:CHEBI:15378, ChEBI:CHEBI:28955,
CC         ChEBI:CHEBI:58052, ChEBI:CHEBI:58223, ChEBI:CHEBI:136974;
CC         Evidence={ECO:0000250|UniProtKB:P22309};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53073;
CC         Evidence={ECO:0000250|UniProtKB:P22309};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=17alpha-estradiol + UDP-alpha-D-glucuronate = 17alpha-
CC         estradiol 3-O-(beta-D-glucuronate) + H(+) + UDP;
CC         Xref=Rhea:RHEA:52868, ChEBI:CHEBI:15378, ChEBI:CHEBI:17160,
CC         ChEBI:CHEBI:57529, ChEBI:CHEBI:58052, ChEBI:CHEBI:58223;
CC         Evidence={ECO:0000250|UniProtKB:P22309};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52869;
CC         Evidence={ECO:0000250|UniProtKB:P22309};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=16beta,17beta-estriol + UDP-alpha-D-glucuronate =
CC         16beta,17beta-estriol 16-O-(beta-D-glucuronate) + H(+) + UDP;
CC         Xref=Rhea:RHEA:52880, ChEBI:CHEBI:15378, ChEBI:CHEBI:58052,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:87620, ChEBI:CHEBI:136886;
CC         Evidence={ECO:0000250|UniProtKB:P22309};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52881;
CC         Evidence={ECO:0000250|UniProtKB:P22309};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=losartan + UDP-alpha-D-glucuronate = losartan-2-N-beta-D-
CC         glucuronide + UDP; Xref=Rhea:RHEA:63720, ChEBI:CHEBI:58052,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:149504, ChEBI:CHEBI:149507;
CC         Evidence={ECO:0000250|UniProtKB:P22309};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63721;
CC         Evidence={ECO:0000250|UniProtKB:P22309};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=prunetin + UDP-alpha-D-glucuronate = prunetin-4'-O-beta-D-
CC         glucuronide + UDP; Xref=Rhea:RHEA:63588, ChEBI:CHEBI:58052,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:147403, ChEBI:CHEBI:147404;
CC         Evidence={ECO:0000250|UniProtKB:P22309};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63589;
CC         Evidence={ECO:0000250|UniProtKB:P22309};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=SN-38 + UDP-alpha-D-glucuronate = H(+) + SN-38 O-beta-D-
CC         glucuronide + UDP; Xref=Rhea:RHEA:63696, ChEBI:CHEBI:8988,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:58052, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:149482; Evidence={ECO:0000250|UniProtKB:P22309};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63697;
CC         Evidence={ECO:0000250|UniProtKB:P22309};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(4Z,15Z)-bilirubin IXalpha + UDP-alpha-D-glucuronate =
CC         (4Z,15Z)-bilirubin IXalpha C12-beta-D-glucuronoside + UDP;
CC         Xref=Rhea:RHEA:75099, ChEBI:CHEBI:57977, ChEBI:CHEBI:58052,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:229705;
CC         Evidence={ECO:0000250|UniProtKB:P22309};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75100;
CC         Evidence={ECO:0000250|UniProtKB:P22309};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(4Z,15Z)-bilirubin IXalpha + UDP-alpha-D-glucuronate =
CC         (4Z,15Z)-bilirubin IXalpha C8-beta-D-glucuronoside + UDP;
CC         Xref=Rhea:RHEA:79067, ChEBI:CHEBI:57977, ChEBI:CHEBI:58052,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:229704;
CC         Evidence={ECO:0000250|UniProtKB:P22309};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:79068;
CC         Evidence={ECO:0000250|UniProtKB:P22309};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(4Z,15Z)-bilirubin IXalpha C8-beta-D-glucuronoside + UDP-
CC         alpha-D-glucuronate = (4Z,15Z)-bilirubin IXalpha C8,C12-beta-D-
CC         bisglucuronoside + UDP; Xref=Rhea:RHEA:79071, ChEBI:CHEBI:58052,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:229704, ChEBI:CHEBI:229706;
CC         Evidence={ECO:0000250|UniProtKB:P22309};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:79072;
CC         Evidence={ECO:0000250|UniProtKB:P22309};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(4Z,15Z)-bilirubin IXalpha C12-beta-D-glucuronoside + UDP-
CC         alpha-D-glucuronate = (4Z,15Z)-bilirubin IXalpha C8,C12-beta-D-
CC         bisglucuronoside + UDP; Xref=Rhea:RHEA:79075, ChEBI:CHEBI:58052,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:229705, ChEBI:CHEBI:229706;
CC         Evidence={ECO:0000250|UniProtKB:P22309};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:79076;
CC         Evidence={ECO:0000250|UniProtKB:P22309};
CC   -!- SUBUNIT: Homodimers. Homooligomer. Interacts with UGT1A3, UGT1A4,
CC       UGT1A6, UGT1A7, UGT1A8, UGT1A9 and UGT1A10 to form heterodimers.
CC       {ECO:0000250|UniProtKB:P22309}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:P22309}; Single-pass membrane protein
CC       {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=1;
CC         Comment=UGT1A1 is one of the isoforms produced at the UGT1A complex
CC         locus. The UGT1A complex locus produces different isoforms based on
CC         alternative use of promoters, first exons and terminal exons.
CC         {ECO:0000250|UniProtKB:P22309};
CC       Name=1;
CC         IsoId=Q64550-1; Sequence=Displayed;
CC   -!- INDUCTION: Induced in 3-methylcholanthrene-treated rats.
CC       {ECO:0000269|PubMed:8554318}.
CC   -!- SIMILARITY: Belongs to the UDP-glycosyltransferase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U20551; AAC52219.1; -; Genomic_DNA.
DR   EMBL; D38065; BAA07260.1; -; Genomic_DNA.
DR   PIR; I57961; I57961.
DR   RefSeq; NP_036815.1; NM_012683.2. [Q64550-1]
DR   AlphaFoldDB; Q64550; -.
DR   SMR; Q64550; -.
DR   IntAct; Q64550; 1.
DR   STRING; 10116.ENSRNOP00000025045; -.
DR   BindingDB; Q64550; -.
DR   ChEMBL; CHEMBL4523339; -.
DR   CAZy; GT1; Glycosyltransferase Family 1.
DR   GlyCosmos; Q64550; 3 sites, No reported glycans.
DR   GlyGen; Q64550; 3 sites.
DR   PhosphoSitePlus; Q64550; -.
DR   SwissPalm; Q64550; -.
DR   PaxDb; 10116-ENSRNOP00000025045; -.
DR   Ensembl; ENSRNOT00000025045.7; ENSRNOP00000025045.4; ENSRNOG00000018740.9. [Q64550-1]
DR   Ensembl; ENSRNOT00055018231; ENSRNOP00055014640; ENSRNOG00055010715. [Q64550-1]
DR   Ensembl; ENSRNOT00060017741; ENSRNOP00060013785; ENSRNOG00060010379. [Q64550-1]
DR   Ensembl; ENSRNOT00065035962; ENSRNOP00065028997; ENSRNOG00065020996. [Q64550-1]
DR   GeneID; 24861; -.
DR   KEGG; rno:24861; -.
DR   AGR; RGD:3935; -.
DR   CTD; 54658; -.
DR   RGD; 3935; Ugt1a1.
DR   eggNOG; KOG1192; Eukaryota.
DR   GeneTree; ENSGT00940000159677; -.
DR   HOGENOM; CLU_012949_3_1_1; -.
DR   InParanoid; Q64550; -.
DR   OrthoDB; 382054at2759; -.
DR   TreeFam; TF315472; -.
DR   BRENDA; 2.4.1.17; 5301.
DR   Reactome; R-RNO-156588; Glucuronidation.
DR   Reactome; R-RNO-189483; Heme degradation.
DR   Reactome; R-RNO-9749641; Aspirin ADME.
DR   Reactome; R-RNO-9753281; Paracetamol ADME.
DR   PRO; PR:Q64550; -.
DR   Proteomes; UP000002494; Chromosome 9.
DR   Bgee; ENSRNOG00000018740; Expressed in duodenum and 20 other cell types or tissues.
DR   ExpressionAtlas; Q64550; baseline and differential.
DR   GO; GO:0070069; C:cytochrome complex; IDA:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HGNC-UCL.
DR   GO; GO:0034663; C:endoplasmic reticulum chaperone complex; ISO:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0019899; F:enzyme binding; IDA:RGD.
DR   GO; GO:0004857; F:enzyme inhibitor activity; ISO:RGD.
DR   GO; GO:0015020; F:glucuronosyltransferase activity; IDA:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0001972; F:retinoic acid binding; ISO:RGD.
DR   GO; GO:0005496; F:steroid binding; ISO:RGD.
DR   GO; GO:0006953; P:acute-phase response; IEP:RGD.
DR   GO; GO:0031100; P:animal organ regeneration; IEP:RGD.
DR   GO; GO:0006789; P:bilirubin conjugation; TAS:RGD.
DR   GO; GO:0070980; P:biphenyl catabolic process; IDA:RGD.
DR   GO; GO:0052695; P:cellular glucuronidation; IDA:RGD.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; IEP:RGD.
DR   GO; GO:0071361; P:cellular response to ethanol; IEP:RGD.
DR   GO; GO:0071385; P:cellular response to glucocorticoid stimulus; IEP:RGD.
DR   GO; GO:0032870; P:cellular response to hormone stimulus; IEP:RGD.
DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0008210; P:estrogen metabolic process; ISO:RGD.
DR   GO; GO:0051552; P:flavone metabolic process; ISO:RGD.
DR   GO; GO:0052696; P:flavonoid glucuronidation; IDA:RGD.
DR   GO; GO:0001889; P:liver development; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0051384; P:response to glucocorticoid; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0007584; P:response to nutrient; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0042594; P:response to starvation; IEP:RGD.
DR   GO; GO:0048545; P:response to steroid hormone; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0052697; P:xenobiotic glucuronidation; IDA:RGD.
DR   CDD; cd03784; GT1_Gtf-like; 1.
DR   Gene3D; 3.40.50.2000; Glycogen Phosphorylase B; 2.
DR   InterPro; IPR050271; UDP-glycosyltransferase.
DR   InterPro; IPR002213; UDP_glucos_trans.
DR   InterPro; IPR035595; UDP_glycos_trans_CS.
DR   PANTHER; PTHR48043; EG:EG0003.4 PROTEIN-RELATED; 1.
DR   PANTHER; PTHR48043:SF157; UDP GLUCURONOSYLTRANSFERASE 1 FAMILY POLYPEPTIDE A3 PRECURSOR-RELATED; 1.
DR   Pfam; PF00201; UDPGT; 1.
DR   SUPFAM; SSF53756; UDP-Glycosyltransferase/glycogen phosphorylase; 1.
DR   PROSITE; PS00375; UDPGT; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Direct protein sequencing; Endoplasmic reticulum;
KW   Glycoprotein; Glycosyltransferase; Lipid metabolism; Membrane;
KW   Reference proteome; Signal; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..29
FT                   /evidence="ECO:0000269|PubMed:7986077"
FT   CHAIN           30..535
FT                   /note="UDP-glucuronosyltransferase 1A1"
FT                   /id="PRO_0000036011"
FT   TRANSMEM        493..509
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        89
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        297
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        435
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CONFLICT        253
FT                   /note="A -> D (in Ref. 2; BAA07260)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   535 AA;  59663 MW;  26B642FCA7DD4082 CRC64;
     MSVVCRSSCS LLLLPCLLLC VLGPSASHAG KLLVIPIDGS HWLSMLGVIQ QLQQKGHEVV
     VIAPEASIHI KEGSFYTMRK YPVPFQNENV TAAFVELGRS VFDQDPFLLR VVKTYNKVKR
     DSSMLLSGCS HLLHNAEFMA SLEQSHFDAL LTDPFLPCGS IVAQYLSLPA VYFLNALPCS
     LDLEATQCPA PLSYVPKSLS SNTDRMNFLQ RVKNMIIALT ENFLCRVVYS PYGSLATEIL
     QKEVTVKDLL SPASIWLMRN DFVKDYPRPI MPNMVFIGGI NCLQKKALSQ EFEAYVNASG
     EHGIVVFSLG SMVSEIPEKK AMEIAEALGR IPQTVLWRYT GTRPSNLAKN TILVKWLPQN
     DLLGHPKARA FITHSGSHGI YEGICNGVPM VMMPLFGDQM DNAKRMETRG AGVTLNVLEM
     TADDLENALK TVINNKSYKE NIMRLSSLHK DRPIEPLDLA VFWVEYVMRH KGAPHLRPAA
     HDLTWYQYHS LDVIGFLLAI VLTVVFIVYK SCAYGCRKCF GGKGRVKKSH KSKTH
//
